Aboelhassan Mohamed, Hasan-Ali Hosam, Mohammed Mohammed Taha, Ashry Amr, Abdelmegid Mohamed Aboel-Kassem F
Department of Cardiology, Faculty of Medicine, Assiut University, Assiut, Egypt.
Department of Cardiothoracic Surgery, Faculty of Medicine, Assiut University, Assiut, Egypt.
Front Cardiovasc Med. 2025 Jun 18;12:1555557. doi: 10.3389/fcvm.2025.1555557. eCollection 2025.
Atrial fibrillation (AF) is the most common sustained arrhythmia in adults and is associated with significant morbidity and mortality. Mitral stenosis (MS) is common in developing countries, affecting the younger population and posing a risk of atrial fibrillation.
This study aims to delineate the clinical characteristics and poor outcomes in patients who have recent non-valvular AF (NVAF) compared with AF related to MS (MS-AF). Furthermore, it seeks to assess the healthcare resource utilization associated with the management of AF patients in the two groups.
This is a prospective observational cohort conducted on 84 patients with recent AF. The patients were divided into two groups: the NVAF group (patients with no prosthetic valves or moderate/severe MS) and the MS-AF group (patients with AF in the presence of moderate/severe MS). The clinical characteristics, stroke risk, and anticoagulation regimens were assessed. AF-related outcomes (strokes, hospitalizations, major bleeding, and mortalities) were monitored and compared between the two groups.
The mean age of the studied AF patients was 49.80 ± 16.31 years, ranging from 25 to 89 years. Patients with MS-AF were significantly younger than patients with NVAF. Hypertension was the most prevalent risk factor associated with AF. Smoking, heart failure, and hypertension were more prevalent among patients with NVAF. The NVAF group received less anticoagulants than the MS-AF group. There were no statistically significant differences between the two groups regarding the overall incidence of death, stroke, myocardial infarction, TIA, or hospital admissions. In the overall studied group, all-cause mortality was higher among AF patients with a history of heart failure or stroke.
Patients with NVAF had a significantly greater incidence of cardiovascular disease risk factors. However, AF related to mitral stenosis was associated with comparable worse outcomes.
心房颤动(AF)是成人中最常见的持续性心律失常,与显著的发病率和死亡率相关。二尖瓣狭窄(MS)在发展中国家很常见,影响年轻人群,并带来心房颤动的风险。
本研究旨在描述近期非瓣膜性心房颤动(NVAF)患者与二尖瓣狭窄相关心房颤动(MS-AF)患者的临床特征和不良结局。此外,它还试图评估两组心房颤动患者管理相关的医疗资源利用情况。
这是一项对84例近期发生心房颤动的患者进行的前瞻性观察队列研究。患者分为两组:NVAF组(无人工瓣膜或中度/重度二尖瓣狭窄的患者)和MS-AF组(存在中度/重度二尖瓣狭窄的心房颤动患者)。评估临床特征、卒中风险和抗凝方案。监测并比较两组的心房颤动相关结局(卒中、住院、大出血和死亡率)。
研究的心房颤动患者的平均年龄为49.80±16.31岁,范围为25至89岁。MS-AF患者明显比NVAF患者年轻。高血压是与心房颤动相关的最普遍危险因素。吸烟、心力衰竭和高血压在NVAF患者中更为普遍。NVAF组接受的抗凝剂比MS-AF组少。两组在死亡、卒中、心肌梗死、短暂性脑缺血发作或住院的总体发生率方面没有统计学显著差异。在整个研究组中,有心力衰竭或卒中病史的心房颤动患者的全因死亡率更高。
NVAF患者心血管疾病危险因素的发生率明显更高。然而,二尖瓣狭窄相关的心房颤动与相当的不良结局相关。